Ignite Creation Date:
2024-05-06 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05739981
Status:
RECRUITING
Last Update Posted:
2024-06-07
First Post:
2023-02-13
Brief Title:
Phase II IMNN-001 Also Known as GEN-1 on SLL With BEV and NACT Newly Diagnosed Advanced Ovarian Fallopian Tube or Primary Peritoneal Cancer
Sponsor:
Imunon
Organization:
Imunon
Organization Data
Organization:
Imunon
Class:
INDUSTRY
Study ID:
201-21-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Imunon
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Break Through Cancer Foundation | UNKNOWN |